Healthcare / Medical Instruments & SuppliesUpdated 2026-05-10 22:07 UTC

AIM/AMS stock hub

AIM/AMS has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

AIM/AMSis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

540.8M

London Stock Exchange AIM

Market data

Live price

Current market quote for this ticker.

Current price

AIM/AMS

In the news

Latest news · AIM/AMS

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E19.4

P25 12.9P50 16.9P75 23.5

Trailing P/E55.3

P25 15.9P50 22.9P75 35.8

ROE4

P25 -54.2P50 2.1P75 13.7

ROIC5

P25 -38.1P50 3.3P75 11.9

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All AIM/AMS market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

248

Groups with data

Currency

GBP

Showing 248 of 248 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United Kingdom
Country code	UK
Employees	1,500
Employees Change	-100%
Employees Change Percent	-6.25
Enterprise value	GBX 605.6M
Exchange	London Stock Exchange AIM
Financial currency	GBP
First seen	2026-05-10
Industry	Medical Instruments & Supplies
Isin	GB0004536594
Last refreshed	2026-05-10
Market cap	GBX 540.8M
Price	GBX 250
Price currency	GBX
Rev Per Employee	152,624x
Sector	Healthcare
Sic	3842
Symbol	aim/AMS
Website	https://www.admedsol.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	1.84%
EV Earnings	60.84x
EV/EBIT	21.27x
EV/EBITDA	12.94x
EV/FCF	24x
EV/Sales	2.65x
FCF yield	4.67%
Forward P/E	19.38x
P/B ratio	2.08x
P/E ratio	55.31x
P/S ratio	2.36x
PE Ratio10 Y	39.76x
PE Ratio3 Y	53.56x
PE Ratio5 Y	44.7x
PEG ratio	0.92x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	12.43%
EBITDA Margin	20.45%
FCF margin	11.02%
Gross margin	53.35%
Gross Profit	GBX 122.1M
Gross Profit Growth	6.23%
Gross Profit Growth Q	12.85%
Gross Profit Growth3 Y	19.61%
Gross Profit Growth5 Y	10.33%
Net Income	GBX 10M
Net Income Growth	40.32%
Net Income Growth Q	28.48%
Net Income Growth Quarters	2%
Net Income Growth Years	1%
Net Income Growth3 Y	-3.66%
Net Income Growth5 Y	-12.74%
Pretax Margin	7.77%
Profit Margin	4.35%
Profit Per Employee	GBX 6,636
Profitable Years	21
ROA	4.54
Roa5y	4.5
ROCE	8.26
ROE	4.02
Roe5y	6.22
ROIC	4.99
Roic5y	8.12

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	4.07%
Cagr15y	8.26%
Cagr1y	29.33%
Cagr20y	16.91%
Cagr3y	2.58%
Cagr5y	-1.35%
Div CAGR10	13.59%
Div CAGR3	9.98%
Div CAGR5	10.96%
EPS Growth	39.08
EPS Growth Q	26.65
EPS Growth Quarters	2
EPS Growth Years	1
EPS Growth3 Y	-4
EPS Growth5 Y	-12.75
FCF Growth	63.49%
FCF Growth Q	24.22%
FCF Growth3 Y	28.7%
FCF Growth5 Y	11.47%
OCF Growth	67.21%
OCF Growth Q	39.29%
OCF Growth10 Y	4.24%
OCF Growth3 Y	29.06%
OCF Growth5 Y	12%
Revenue Growth	28.96x
Revenue Growth Q	7.88x
Revenue Growth Quarters	4x
Revenue Growth Years	5x
Revenue Growth3 Y	20.42x
Revenue Growth5 Y	12.14x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	GBX 0.58
Assets	GBX 394.8M
Cash	GBX 18M
Current Assets	GBX 139.4M
Current Liabilities	GBX 49.9M
Debt	GBX 81.5M
Debt EBITDA	GBX 1.74
Debt Equity	GBX 0.31
Debt FCF	GBX 3.23
Equity	GBX 260.1M
Interest Coverage	5.59
Liabilities	GBX 134.7M
Long Term Assets	GBX 255.4M
Long Term Liabilities	GBX 84.7M
Net Cash	GBX -63.5M
Net Cash By Market Cap	GBX -11.74
Net Debt EBITDA	GBX 1.36
Net Debt Equity	GBX 0.24
Net Debt FCF	GBX 2.52
Tangible Book Value	GBX 53.4M
Tangible Book Value Per Share	GBX 0.25
WACC	7.59

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.79
Inventory Turnover	1.7
Net Working Capital	GBX 86.1M
Quick ratio	1.36
Working Capital	GBX 89.4M
Working Capital Turnover	GBX 2.67

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.78%
Dividend Growth	10%
Dividend Growth Years	13%
Dividend per share	GBX 0.03
Dividend Years	16
Dividend Yield	1.14%
Ex Div Date	2026-05-28
Last Dividend	GBX 0.02
Payout Frequency	Semi-Annual
Payout Ratio	58.18%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	48.96%
1Y total return	29.31%
200-day SMA	214.5
3Y total return	7.96%
50-day SMA	215.6
50-day SMA vs 200-day SMA	50over200
5Y total return	-6.55%
All Time High	374
All Time High Change	-33.16%
All Time High Date	2018-07-31
All Time Low	6
All Time Low Change	4,066.67%
All Time Low Date	2002-08-21
ATR	8.43
Beta	0.72
Beta1y	0.62
Beta2y	0.8
Ch YTD	14.68
High	250.5
High52	272
High52 Date	2026-04-20
High52ch	-8.09%
Low	245
Low52	185.6
Low52 Date	2025-05-19
Low52ch	34.7%
Ma50ch	15.98%
Price vs 200-day SMA	16.57%
RSI	66.01
RSI Monthly	57.79
RSI Weekly	64.39
Sharpe ratio	0.89x
Sortino ratio	1.78
Total Return	0.36%
Tr YTD	14.68
Tr15y	228.76%
Tr1m	26.78%
Tr1w	4.17%
Tr3m	15.21%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	GBX 28.5M
Operating Income Growth	58.12
Operating Income Growth Q	143.8
Operating Income Growth3 Y	31.85
Operating Income Growth5 Y	4.3
Operating margin	12.43

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	170,705,635%
Net Borrowing	-9,461,000
Shares Insiders	1.56%
Shares Institutions	80.7%
Shares Out	216,314,320
Shares Qo Q	1.12%
Shares Yo Y	0.78%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	GBX 21.1M
Average Volume	1,334,192.15x
Bv Per Share	1.2
CAPEX	GBX -7.4M
Ch10y	38.89
Ch15y	197.6
Ch1m	26.78
Ch1w	4.17
Ch1y	27.68
Ch20y	1,959.3
Ch3m	15.21
Ch3y	4.38
Ch5y	-10.87
Ch6m	17.37
Change	0.81%
Change From Open	0
Close	248
Days Gap	0.81
Depreciation Amortization	18,349,000
Dollar Volume	264,493,250
Earnings Date	2026-06-16
EBIT	GBX 28.5M
EBITDA	GBX 46.8M
EPS	GBX 0.05
F Score	7
FCF	GBX 25.2M
FCF EV Yield	4.17x
FCF Per Share	GBX 0.12
Financing CF	-18,968,000
Fiscal Year End	December
Founded	1,991
Goodwill	112,693,000
Graham Number	110.344
Graham Upside	-55.86
Income Tax	GBX 7.7M
Investing CF	-13,331,000
Is Primary Listing	1
Last Earnings Date	2026-03-18
Last Report Date	2025-12-31
Lynch Fair Value	GBX 22.6
Lynch Upside	-90.96
Ma150	216.8
Ma150ch	15.33%
Ma20	240.7
Ma20ch	3.89%
Net CF	976,000
Next Earnings Date	2026-06-16
Open	250
P FCF Ratio	21.44
P OCF Ratio	16.6
Payment Date	2026-06-26
Position In Range	90.91
Ppne	48,750,000
Price Date	2026-05-08
Price EBITDA	GBX 11.55
Ptbv Ratio	10.13
Relative Volume	0.82x
Revenue	228,936,000x
SBC By Revenue	1.81x
Share Based Comp	4,140,000
Tax By Revenue	3.36x
Tax Rate	43.23%
Tr20y	2,174.78%
Tr6m	17.37%
Volume	1,057,973
Z Score	3.74

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

AIM/AMS dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+1.1%

$0.03 annual per share

Payout ratio

+58.2%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+11.0%

13 consecutive years of growth

Total shareholder yield

+0.4%

Next ex-dividend date: 2026-05-28

Performance

AIM/AMS stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns AIM/AMS?

Insider, institutional, and short-interest positioning.

Institutional ownership

+80.7%

Share of float held by funds and institutions

Insider ownership

+1.6%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+0.8%

Negative means the company is buying back shares.

Technical

AIM/AMS momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

66.0

Neutral momentum band

Price vs 200-day MA

+16.6%

50/200-day relationship not available

Beta (5Y)

0.72

Less volatile than the market

Sharpe ratio

0.89

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About AIM/AMS

Hub-level FAQ points readers to the deeper analysis pages.

What is the current aim/AMS stock rating?

aim/AMS is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full aim/AMS analysis?

The full report lives at /stocks/aim/AMS/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for aim/AMS?

The latest report frames aim/AMS around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the aim/AMS page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.